Shares of Cronos Group Inc. (NASDAQ:CRON – Get Free Report) crossed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $3.32 and traded as low as $3.25. Cronos Group shares last traded at $3.27, with a volume of 911,176 shares changing hands.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on CRON shares. Zacks Research upgraded shares of Cronos Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 22nd. Wall Street Zen upgraded Cronos Group from a “hold” rating to a “buy” rating in a report on Saturday, November 7th. TD Securities restated a “buy” rating on shares of Cronos Group in a report on Monday, September 28th. Finally, Weiss Ratings raised Cronos Group from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, Cronos Group has an average rating of “Buy” and a consensus target price of $2.30.
Get Our Latest Analysis on CRON
Cronos Group Stock Down 3.3%
The stock’s 50-day moving average price is $3.32 and its 200 day moving average price is $2.90. The firm has a market cap of $1.20 billion, a price-to-earnings ratio of 19.24 and a beta of 0.96.
Cronos Group (NASDAQ:CRON – Get Free Report) last released its earnings results on Thursday, November 5th. The company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. Cronos Group had a return on equity of 2.56% and a net margin of 28.04%. The business had revenue of $63.45 million for the quarter, compared to the consensus estimate of $51.15 million. On average, research analysts predict that Cronos Group Inc. will post 0.16 EPS for the current year.
Institutional Trading of Cronos Group
Several institutional investors have recently modified their holdings of the company. Cibc World Market Inc. acquired a new position in Cronos Group in the second quarter worth about $3,820,000. Pillsbury Lake Capital LLC acquired a new stake in Cronos Group during the second quarter valued at approximately $2,252,253. HighTower Advisors LLC acquired a new stake in Cronos Group during the third quarter valued at approximately $1,198,000. Parallax Volatility Advisers L.P. acquired a new stake in Cronos Group during the second quarter valued at approximately $834,000. Finally, Corient Private Wealth LP bought a new stake in shares of Cronos Group in the 2nd quarter valued at approximately $595,000. Institutional investors and hedge funds own 8.71% of the company’s stock.
About Cronos Group
Cronos Group is a cannabinoid company that develops, produces, and markets cannabis and cannabis-derived products. Its business includes cultivation, processing, product development, and distribution. The company sells products in categories such as dried cannabis flower, pre-rolls, vaporizers, edibles, and extracts. Its brand portfolio includes Spinach and PEACE NATURALS. Founded in 2012 and headquartered in Toronto, Cronos serves consumers in Canada and select international markets, including Israel.
Featured Articles
- Five stocks we like better than Cronos Group
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.
